TScan Therapeutics (TCRX) Stock Chart & Stock Price History → Crypto Millionaire Says: “Buy This $11 AI Coin.” (From InvestorPlace) (Ad) Free TCRX Stock Alerts $8.01 +0.28 (+3.62%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TScan Therapeutics Stock Price Performance5 Day Performance+2.69%1 Month Performance+3.35%3 Month Performance+38.10%6 Month Performance+60.20%Year-To-Date Performance+37.39%1 Year Performance+103.82% Receive TCRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him TCRX Stock Chart for Tuesday, May, 14, 2024 TCRX Chart by TradingView TScan Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$7.73$8.01+3.62%$8.17$7.51149,406 shs$383.52 million05/10/2024$7.80$7.73-0.90%$8.22$7.67114,183 shs$370.11 million05/09/2024$8.01$7.80-2.62%$7.98$7.34238,808 shs$373.46 million05/08/2024$8.67$8.01-7.61%$8.72$7.98111,212 shs$383.52 million05/07/2024$8.81$8.67-1.59%$8.95$8.58104,556 shs$415.12 million05/06/2024$8.56$8.81+2.92%$8.91$8.4297,441 shs$421.84 million Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$8.65$8.56-1.04%$9.09$8.5588,678 shs$409.85 million05/02/2024$8.62$8.65+0.35%$8.81$8.55229,162 shs$414.16 million05/01/2024$7.72$8.62+11.66%$8.70$7.75263,182 shs$412.74 million04/30/2024$7.68$7.72+0.52%$7.90$7.38289,874 shs$369.63 million04/29/2024$7.32$7.68+4.92%$7.82$7.41205,982 shs$367.72 million04/26/2024$7.29$7.32+0.41%$7.46$7.1292,052 shs$350.48 million04/25/2024$7.38$7.29-1.22%$7.46$7.04107,354 shs$349.05 million04/24/2024$7.26$7.38+1.65%$7.51$7.1189,303 shs$353.35 million04/23/2024$7.12$7.26+1.97%$7.55$7.02208,208 shs$347.61 million04/22/2024$6.82$7.12+4.40%$7.24$6.74173,211 shs$340.92 million04/19/2024$6.92$6.82-1.45%$7.13$6.71278,857 shs$326.54 million04/18/2024$6.75$6.92+2.52%$7.14$6.65250,511 shs$331.33 million04/17/2024$7.13$6.75-5.33%$7.36$6.581.64 million shs$323.19 million04/16/2024$7.69$7.13-7.28%$7.55$7.1298,718 shs$341.38 million04/15/2024$7.75$7.69-0.77%$7.92$7.44121,516 shs$368.20 million04/12/2024$7.80$7.75-0.64%$8.12$7.49128,926 shs$371.07 million04/11/2024$7.23$7.80+7.88%$7.87$7.21168,153 shs$373.46 million04/10/2024$7.45$7.23-2.95%$7.41$7.08131,547 shs$346.17 million04/09/2024$7.34$7.45+1.50%$7.82$7.3594,954 shs$356.71 million04/08/2024$7.09$7.34+3.53%$7.36$7.0370,509 shs$351.45 million04/05/2024$7.09$7.09$7.20$7.00105,837 shs$339.47 million04/04/2024$7.16$7.09-0.98%$7.33$6.98161,683 shs$339.48 million04/03/2024$7.20$7.16-0.56%$7.45$7.01125,111 shs$342.82 million04/02/2024$8.01$7.20-10.11%$7.99$7.14126,282 shs$344.74 million04/01/2024$7.94$8.01+0.88%$8.16$7.72121,823 shs$383.52 million03/29/2024$7.94$7.94$8.29$7.28741,662 shs$380.17 million03/28/2024$8.30$7.94-4.34%$8.27$7.28741,662 shs$380.17 million03/27/2024$7.99$8.30+3.88%$9.00$7.97448,974 shs$397.40 million03/26/2024$7.93$7.99+0.76%$8.24$7.91226,624 shs$382.56 million03/25/2024$8.02$7.93-1.12%$8.42$7.70397,286 shs$379.69 million03/22/2024$7.01$8.02+14.41%$8.06$7.17527,881 shs$384.00 million03/21/2024$7.01$7.01$7.09$6.8186,926 shs$335.64 million03/20/2024$6.97$7.01+0.57%$7.12$6.8886,651 shs$335.64 million03/19/2024$6.83$6.97+2.05%$7.19$6.6196,723 shs$333.74 millionMillionaire investor and Republican donor makes surprising election prediction (Ad)Find out who Louis believes is going to win the election... And why that will launch a second boom in AI stocksClick for his six specific AI stock in the crosshairs03/18/2024$7.12$6.83-4.07%$7.40$6.8193,403 shs$326.68 million03/15/2024$6.79$7.12+4.86%$7.12$6.56347,939 shs$340.55 million03/14/2024$6.71$6.79+1.19%$6.89$6.5593,537 shs$324.73 million03/13/2024$6.76$6.71-0.74%$7.09$6.4575,479 shs$320.94 million03/12/2024$6.56$6.76+3.05%$6.90$6.4365,790 shs$323.33 million03/11/2024$6.55$6.56+0.15%$6.88$6.4248,155 shs$313.77 million03/08/2024$7.14$6.55-8.26%$7.25$6.40157,969 shs$313.29 million03/07/2024$7.15$7.14-0.14%$7.35$6.98103,877 shs$341.51 million03/06/2024$7.03$7.15+1.71%$7.35$6.80139,354 shs$341.98 million03/05/2024$7.12$7.03-1.26%$7.17$6.7534,942 shs$336.21 million03/04/2024$7.20$7.12-1.11%$7.28$6.9497,560 shs$340.55 million03/01/2024$6.75$7.20+6.67%$7.67$6.77224,553 shs$344.38 million02/29/2024$6.71$6.75+0.60%$6.97$6.50139,876 shs$322.82 million02/28/2024$6.45$6.71+4.03%$6.97$6.22342,141 shs$320.94 million02/27/2024$6.79$6.45-5.01%$6.79$6.15183,989 shs$308.50 million02/26/2024$6.76$6.79+0.44%$7.05$6.66123,721 shs$324.77 million02/23/2024$6.82$6.76-0.88%$6.78$6.40100,574 shs$323.33 million02/22/2024$6.95$6.82-1.87%$7.00$6.5273,795 shs$326.20 million02/21/2024$7.41$6.95-6.21%$7.31$6.74236,502 shs$332.42 million02/20/2024$6.78$7.41+9.29%$7.86$6.77727,170 shs$354.42 million02/19/2024$6.78$6.78$7.10$5.56655,700 shs$324.25 million02/16/2024$5.74$6.78+18.12%$7.10$5.56655,109 shs$324.29 million02/15/2024$5.80$5.74-1.03%$5.99$5.6077,078 shs$274.52 million02/14/2024$5.73$5.80+1.22%$5.89$5.6658,365 shs$277.41 million02/13/2024$5.94$5.73-3.54%$6.05$5.55132,294 shs$274.07 million Related Companies: Replimune Group Stock Chart Tourmaline Bio Stock Chart Ocugen Stock Chart Alvotech Stock Chart Solid Biosciences Stock Chart Fate Therapeutics Stock Chart Lexeo Therapeutics Stock Chart iTeos Therapeutics Stock Chart Black Diamond Therapeutics Stock Chart Adaptive Biotechnologies Stock Chart Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe only AI company you should be looking atBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressNo experience to confident trader, meet my student…Wealth Builders InstituteCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOIC Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.